Premium
Impact of migraine and migraine therapy on productivity and quality of life. (Merck Research Laboratories, Merck & Co., West Point, PA) Neurology 2000;55:S29–S35.
Author(s) -
Solomon Glen D.,
Santanello Nancy
Publication year - 2001
Publication title -
pain practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 58
eISSN - 1533-2500
pISSN - 1530-7085
DOI - 10.1046/j.1533-2500.2001.01023-23.x
Subject(s) - migraine , absenteeism , productivity , medicine , quality of life (healthcare) , migraine treatment , neurology , intervention (counseling) , rizatriptan , psychiatry , physical therapy , psychology , nursing , sumatriptan , economics , agonist , macroeconomics , social psychology , receptor
Migraine is an expensive disorder in terms of lost productivity and its deleterious impact on health‐related quality of life (QOL). In addition to lost wages and productivity due to absenteeism, many patients with migraine also experience reduced productivity while at work and disruption of their family, social, and leisure activities. Therefore, this article began with a discussion on the impact of migraine on work productivity and then measured the QOL in migraine sufferers. Pharmaceutical intervention was discussed. It was concluded that compared with usual care, rizatriptan had favorable effects on all five domains of the 24‐h Migraine QOL questionnaire.